MDT Q2 2023 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.6B-3.3% YoY

Gross Profit

$5.0B66.6% margin

Operating Income

$1.4B18.5% margin

Net Income

$427M5.6% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$922M

Free Cash Flow

$599M

Stock-Based Comp.

$137M

Balance Sheet

Total Assets

$93.2B

Total Liabilities

$41.2B

Stockholders' Equity

$51.9B

Cash & Equivalents

$4.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.6B	$7.8B	-3.3%
Gross Profit	$5.0B	$5.3B	-5.6%
Operating Income	$1.4B	$1.6B	-10.2%
Net Income	$427M	$1.3B	-67.4%

Revenue Segments

Cardiovascular

$2.8B37%

Neuroscience Group

$2.2B29%

Medical Surgical

$2.1B27%

Diabetes Group

$556M7%

Geographic Segments

UNITED STATES

$4.1B54%

Total Other Countries, Excluding United States and Ireland

$3.5B46%

IRELAND

$25M0%